Related Experiment Video
Updated: Jun 2, 2025

Author Spotlight: An Optimized Automated Method for Investigating Retinoic Acid Receptors in Neuronal Mitochondria
Published on: July 28, 2023
Mitochondrial Electron Flow Dynamics Imaging for Assessing Mitochondrial Quality and Drug Screening
Youxiao Ren1, Ling-Ling Wu1, Wenjing Song1
1State Key Laboratory of Advanced Drug Delivery and Release Systems, School of Pharmaceutical Sciences, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
Researchers developed a novel tracker to monitor mitochondrial electron flow (Mito-EF), revealing its aggregation in healthy mitochondria. This tool aids in understanding mitochondrial quality control and drug screening.
Area of Science:
- Cell Biology
- Mitochondrial Biology
- Biotechnology
Background:
- Mitochondrial quality control is crucial for cellular function.
- Mitochondrial electron flow (Mito-EF) is vital for homeostasis but difficult to track.
- Existing methods struggle to monitor invisible factors like Mito-EF.
Purpose of the Study:
- To develop a novel tracker for Mito-EF.
- To elucidate Mito-EF's role in mitochondrial quality control.
- To introduce Mito-EF as a drug screening parameter.
Main Methods:
- Development of a four-pronged Mito-EF tracker (Mito-EFT).
- Monitoring Mito-EF aggregation in relation to mitochondrial morphology.
- Correlating Mito-EF signals with mitochondrial fission, fusion, and cristae structure.
Main Results:
- Mito-EF aggregates more in healthy, fiber-like mitochondria than damaged, round-like ones.
- Mito-EF aggregation correlates with mitochondrial remodeling during fission and fusion.
- Mito-EF signals are associated with Dynamin-Related Protein 1 (DRP1)-maintained mitochondrial cristae.
Conclusions:
- Mito-EF is a key factor in assessing mitochondrial quality control.
- The Mito-EFT provides a new tool for studying mitochondrial homeostasis.
- Mito-EF can serve as a novel parameter for drug screening targeting mitochondria.

